The global Urokinase for Injection market size was valued at US$ 678.2 million in 2024 and is projected to reach US$ 892.5 million by 2030, at a CAGR of 4.7% during the forecast period 2024-2030.
The United States Urokinase for Injection market size was valued at US$ 187.3 million in 2024 and is projected to reach US$ 241.6 million by 2030, at a CAGR of 4.3% during the forecast period 2024-2030.
Urokinase for injection is a thrombolytic agent used to dissolve blood clots in various medical conditions, including pulmonary embolism, deep vein thrombosis, and myocardial infarction.
The Urokinase for Injection market is growing moderately, driven by the increasing prevalence of thrombotic disorders and cardiovascular diseases globally. The market benefits from urokinase's established efficacy profile and its use in specific clinical scenarios. There's ongoing research into new applications, including potential use in cancer therapy. The market is seeing efforts to improve production processes for enhanced purity and cost-effectiveness. Challenges include competition from newer thrombolytic agents and managing the risk of bleeding complications associated with treatment. The aging global population and the rising incidence of lifestyle-related cardiovascular diseases are expected to support continued market growth.
Report Overview
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals.
This report provides a deep insight into the global Urokinase for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Urokinase for Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Urokinase for Injection market in any manner.
Global Urokinase for Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Market Segmentation (by Type)
Urokinase Powder
Urokinase Solution
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Urokinase for Injection
1.2 Key Market Segments
1.2.1 Urokinase for Injection Segment by Type
1.2.2 Urokinase for Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Urokinase for Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Urokinase for Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Urokinase for Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Urokinase for Injection Market Competitive Landscape
3.1 Global Urokinase for Injection Sales by Manufacturers (2019-2024)
3.2 Global Urokinase for Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Urokinase for Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Urokinase for Injection Sales Sites, Area Served, Product Type
3.6 Urokinase for Injection Market Competitive Situation and Trends
3.6.1 Urokinase for Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Urokinase for Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Urokinase for Injection Industry Chain Analysis
4.1 Urokinase for Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Urokinase for Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Urokinase for Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Urokinase for Injection Sales Market Share by Type (2019-2024)
6.3 Global Urokinase for Injection Market Size Market Share by Type (2019-2024)
6.4 Global Urokinase for Injection Price by Type (2019-2024)
7 Urokinase for Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Urokinase for Injection Market Sales by Application (2019-2024)
7.3 Global Urokinase for Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Urokinase for Injection Sales Growth Rate by Application (2019-2024)
8 Urokinase for Injection Market Segmentation by Region
8.1 Global Urokinase for Injection Sales by Region
8.1.1 Global Urokinase for Injection Sales by Region
8.1.2 Global Urokinase for Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Urokinase for Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Urokinase for Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Urokinase for Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Urokinase for Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Urokinase for Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 NDPharm
9.1.1 NDPharm Urokinase for Injection Basic Information
9.1.2 NDPharm Urokinase for Injection Product Overview
9.1.3 NDPharm Urokinase for Injection Product Market Performance
9.1.4 NDPharm Business Overview
9.1.5 NDPharm Urokinase for Injection SWOT Analysis
9.1.6 NDPharm Recent Developments
9.2 Wanhua Biochem
9.2.1 Wanhua Biochem Urokinase for Injection Basic Information
9.2.2 Wanhua Biochem Urokinase for Injection Product Overview
9.2.3 Wanhua Biochem Urokinase for Injection Product Market Performance
9.2.4 Wanhua Biochem Business Overview
9.2.5 Wanhua Biochem Urokinase for Injection SWOT Analysis
9.2.6 Wanhua Biochem Recent Developments
9.3 Jiangxi Haoran Bio-Pharma
9.3.1 Jiangxi Haoran Bio-Pharma Urokinase for Injection Basic Information
9.3.2 Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Overview
9.3.3 Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Market Performance
9.3.4 Jiangxi Haoran Bio-Pharma Urokinase for Injection SWOT Analysis
9.3.5 Jiangxi Haoran Bio-Pharma Business Overview
9.3.6 Jiangxi Haoran Bio-Pharma Recent Developments
9.4 Jiangsu Aidea Pharmaceutical
9.4.1 Jiangsu Aidea Pharmaceutical Urokinase for Injection Basic Information
9.4.2 Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Overview
9.4.3 Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Market Performance
9.4.4 Jiangsu Aidea Pharmaceutical Business Overview
9.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
10 Urokinase for Injection Market Forecast by Region
10.1 Global Urokinase for Injection Market Size Forecast
10.2 Global Urokinase for Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Urokinase for Injection Market Size Forecast by Country
10.2.3 Asia Pacific Urokinase for Injection Market Size Forecast by Region
10.2.4 South America Urokinase for Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Urokinase for Injection by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Urokinase for Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Urokinase for Injection by Type (2025-2030)
11.1.2 Global Urokinase for Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Urokinase for Injection by Type (2025-2030)
11.2 Global Urokinase for Injection Market Forecast by Application (2025-2030)
11.2.1 Global Urokinase for Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Urokinase for Injection Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Urokinase for Injection Market Size Comparison by Region (M USD)
Table 5. Global Urokinase for Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Urokinase for Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Urokinase for Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Urokinase for Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase for Injection as of 2022)
Table 10. Global Market Urokinase for Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Urokinase for Injection Sales Sites and Area Served
Table 12. Manufacturers Urokinase for Injection Product Type
Table 13. Global Urokinase for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Urokinase for Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Urokinase for Injection Market Challenges
Table 22. Global Urokinase for Injection Sales by Type (Kilotons)
Table 23. Global Urokinase for Injection Market Size by Type (M USD)
Table 24. Global Urokinase for Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Urokinase for Injection Sales Market Share by Type (2019-2024)
Table 26. Global Urokinase for Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Urokinase for Injection Market Size Share by Type (2019-2024)
Table 28. Global Urokinase for Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Urokinase for Injection Sales (Kilotons) by Application
Table 30. Global Urokinase for Injection Market Size by Application
Table 31. Global Urokinase for Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Urokinase for Injection Sales Market Share by Application (2019-2024)
Table 33. Global Urokinase for Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Urokinase for Injection Market Share by Application (2019-2024)
Table 35. Global Urokinase for Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Urokinase for Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Urokinase for Injection Sales Market Share by Region (2019-2024)
Table 38. North America Urokinase for Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Urokinase for Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Urokinase for Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Urokinase for Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Urokinase for Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. NDPharm Urokinase for Injection Basic Information
Table 44. NDPharm Urokinase for Injection Product Overview
Table 45. NDPharm Urokinase for Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. NDPharm Business Overview
Table 47. NDPharm Urokinase for Injection SWOT Analysis
Table 48. NDPharm Recent Developments
Table 49. Wanhua Biochem Urokinase for Injection Basic Information
Table 50. Wanhua Biochem Urokinase for Injection Product Overview
Table 51. Wanhua Biochem Urokinase for Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Wanhua Biochem Business Overview
Table 53. Wanhua Biochem Urokinase for Injection SWOT Analysis
Table 54. Wanhua Biochem Recent Developments
Table 55. Jiangxi Haoran Bio-Pharma Urokinase for Injection Basic Information
Table 56. Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Overview
Table 57. Jiangxi Haoran Bio-Pharma Urokinase for Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Jiangxi Haoran Bio-Pharma Urokinase for Injection SWOT Analysis
Table 59. Jiangxi Haoran Bio-Pharma Business Overview
Table 60. Jiangxi Haoran Bio-Pharma Recent Developments
Table 61. Jiangsu Aidea Pharmaceutical Urokinase for Injection Basic Information
Table 62. Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Overview
Table 63. Jiangsu Aidea Pharmaceutical Urokinase for Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Jiangsu Aidea Pharmaceutical Business Overview
Table 65. Jiangsu Aidea Pharmaceutical Recent Developments
Table 66. Global Urokinase for Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Urokinase for Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Urokinase for Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Urokinase for Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Urokinase for Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Urokinase for Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Urokinase for Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Urokinase for Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Urokinase for Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Urokinase for Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Urokinase for Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Urokinase for Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Urokinase for Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Urokinase for Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Urokinase for Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Urokinase for Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Urokinase for Injection Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Urokinase for Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Urokinase for Injection Market Size (M USD), 2019-2030
Figure 5. Global Urokinase for Injection Market Size (M USD) (2019-2030)
Figure 6. Global Urokinase for Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Urokinase for Injection Market Size by Country (M USD)
Figure 11. Urokinase for Injection Sales Share by Manufacturers in 2023
Figure 12. Global Urokinase for Injection Revenue Share by Manufacturers in 2023
Figure 13. Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Urokinase for Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Urokinase for Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Urokinase for Injection Market Share by Type
Figure 18. Sales Market Share of Urokinase for Injection by Type (2019-2024)
Figure 19. Sales Market Share of Urokinase for Injection by Type in 2023
Figure 20. Market Size Share of Urokinase for Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Urokinase for Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Urokinase for Injection Market Share by Application
Figure 24. Global Urokinase for Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Urokinase for Injection Sales Market Share by Application in 2023
Figure 26. Global Urokinase for Injection Market Share by Application (2019-2024)
Figure 27. Global Urokinase for Injection Market Share by Application in 2023
Figure 28. Global Urokinase for Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Urokinase for Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Urokinase for Injection Sales Market Share by Country in 2023
Figure 32. U.S. Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Urokinase for Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Urokinase for Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Urokinase for Injection Sales Market Share by Country in 2023
Figure 37. Germany Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Urokinase for Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Urokinase for Injection Sales Market Share by Region in 2023
Figure 44. China Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Urokinase for Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Urokinase for Injection Sales Market Share by Country in 2023
Figure 51. Brazil Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Urokinase for Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Urokinase for Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Urokinase for Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Urokinase for Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Urokinase for Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Urokinase for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Urokinase for Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Urokinase for Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Urokinase for Injection Market Share Forecast by Application (2025-2030)
